Timmerman Report
The Long Run with Luke Timmerman
"The Long Run"Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join ho...
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Ep29: John Wilbanks 16.10.2018 1:10:15
John Wilbanks on making it easy to share biological data.
Ep28: Sabah Oney 02.10.2018 1:08:32
Sabah Oney on becoming a scientific business executive.
Ep27: Amy Abernethy 18.09.2018 58:11
Amy Abernethy on making EHRs useful for drug development.
Ep26: Meg Tirrell 05.09.2018 55:03
Meg Tirrell on covering biotech on TV.
Ep25: Thong Le 21.08.2018 1:02:47
Thong Le on building startups to suit pharma needs.
Ep24: Ankit Mahadevia 07.08.2018 59:17
Ankit Mahadevia on the antibiotic opportunity
Ep23: Chris Garabedian 24.07.2018 1:03:13
Chris Garabedian on the "middle market" of biotech VC.
Ep22: Vicki Sato (Take 2) 09.07.2018 1:05:09
Vicki Sato on her career in biotech.
Ep21: Tony Coles 21.06.2018 1:01:57
Tony Coles on neurodegenerative drug discovery and inclusive leadership.
Ep20: Rob Perez 04.06.2018 1:04:12
Ep20: Rob Perez by Timmerman Report
Ep19: Chip Clark 09.05.2018 1:05:16
Ep19: Chip Clark by Timmerman Report
Ep18: Ethan Perlstein 09.05.2018 1:04:10
Ep18: Ethan Perlstein by Timmerman Report
Ep17: Alice Zhang 24.04.2018 58:02
Ep17: Alice Zhang by Timmerman Report
Ep14: Michael Gilman 13.03.2018 1:01:10
Michael Gilman on becoming an entrepreneur.
Ep13: Bruce Booth 28.02.2018 58:29
Bruce Booth on human capital
Ep12: David Schenkein 13.02.2018 59:06
Agios CEO David Schenkein on building a cancer R&D engine to last.
Ep11: Stephane Bancel 31.01.2018 1:06:13
Stephane Bancel, CEO of Moderna Therapeutics, on his influences.
Ep10: Abbie Celniker 16.01.2018 51:39
Abbie Celniker of Third Rock Ventures on her career, and chipping away at gender inequities in biotech.
Ep9: Bob More 02.01.2018 49:17
Bob More on biotech venture capital
Ep8: BioMarin History 20.12.2017 1:01:38
Daniel Levine & Dan Maher discuss their book "A Rare Breed."
Ep7: Steve Graham 05.12.2017 57:34
Steve Graham on racism in Corporate America.
Ep6: Steve Holtzman 29.11.2017 59:54
Ep6: Steve Holtzman of Decibel Therapeutics on political activism among biotech CEOs.
Ep5: Elias Zerhouni 08.11.2017 47:05
Elias Zerhouni, president of R&D at Sanofi, on immigration in science and the importance of government science funding.
Ep4: Richard Pops 24.10.2017 56:30
Alkermes CEO Richard Pops on fighting the opioid painkiller crisis.
Ep3: George Yancopoulos 10.10.2017 58:07
Interview with Regeneron president and CSO George Yancopoulos
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.